Search results (18)
« Back to NewsProfessor Samira Lakhal-Littleton authors article on iron deficiency and supplementation in heart failure for Nature Reviews Cardiology
9 February 2024
Professor Lakhal-Littleton, an Oxford BHF CRE PI, and her team have investigated non-anaemic iron deficiency in cardiovascular medicine due to its association with a range of adverse effects in various conditions. Lessons learned could ultimately translate into benefits for patients with other conditions such as chronic kidney disease, chronic obstructive pulmonary disease and cancer.
Having a healthier heart associated with better problem-solving and reaction time
17 May 2021
People with healthier heart structure and function appear to have better cognitive abilities, including increased capacity to solve logic problems and faster reaction times, according to a study involving University of Oxford and Queen Mary University of London (QMUL) researchers.
Study provides new insights into causal mechanisms for atrial fibrillation
13 May 2021
A large-scale genetic study, led by Oxford BHF researchers Dr Parag Gajendragadkar, clinical DPhil student, Professor Barbara Casadei and Professor Jemma Hopewell, has shed new light on common heart rhythm disturbances
New target identified to develop treatment for Abdominal Aortic Aneurysm
30 March 2021
A new study from the Smart group has shed light on a key regulatory step in the initiation and progression of Abdominal Aortic Aneurysm by revealing the protective role of a previously little known small protein.
New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy
19 November 2020
New research led by Oxford BHF CRE Intermediate Transition Fellow Dr Kerstin Timm shows that a recently developed imaging technique pioneered by the Tyler Group can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.
Bone hormone could provide new treatment for heart rhythm disorder
6 November 2020
A hormone which helps regulate bone mass is also produced by the heart and could help treat people with a dangerous heart rhythm disorder, according to a new study published in the journal Nature.
New study enables identification of people at particular risk of rare, but serious, muscle-related side effect of statin therapy
24 July 2020
Researchers at the Nuffield Department of Population Health, in collaboration with other researchers, have published new findings that identify a combination of factors that put some patients at higher risk of myopathy.
RDM team wins 2018 Hypertension Top Paper award
19 August 2019
Award from the journal Hypertension recognises publication as the top paper in its category of basic science.
Key British Heart Foundation funded research from Mommersteeg Group published in Cell Reports
20 November 2018
The Mexican tetra fish can repair its heart after damage. The Mommersteeg Group's paper "Heart regeneration in the Mexican cavefish" suggests that a particular gene may hold the key to this inherent ability. If they can lock down exactly how this works, it may be possible to revolutionise how we heal damaged human hearts.
Premature hearts less able to cope with exercise
19 March 2018
The hearts of people born prematurely are less able to cope with the pressures of exercise in adulthood, according to a new study published in the Journal of the American College of Cardiology and part-funded by the British Heart Foundation and the NIHR Oxford Biomedical Research Centre.
From bug to drug: tick saliva could be key to treating heart disease
27 June 2017
Proteins found in tick saliva could be used to treat a potentially fatal form of heart disease, according to new Oxford University research.